Karachi: Hoechst Pakistan Limited has disclosed a recent transaction involving its associated company, Nera Pharma (SMC-Pvt.) Limited. The company announced that Nera Pharma executed a share purchase involving 994 shares at a rate of Rs. 3,950 per share on October 23, 2026. This transaction brings Nera Pharma's cumulative shareholding to 524,194 shares, representing a cumulative percentage of 5.44%.

According to information available from the Pakistan Stock Exchange (PSX), the transaction will be presented at the upcoming board meeting of Hoechst Pakistan Limited for consideration in compliance with clause 5.6.4 of the PSX regulations. The company has confirmed adherence to the required holding period of over six months for these transactions. Should any transaction fall within six months, the profit equivalent will be deposited with the Securities and Exchange Commission of Pakistan (SECP), as mandated by Section 105 of the Securities Act, 2015.

The transaction is classified within the designated market category as a regulatory requirement, aligning with the company's obligations toward transparency and regulatory compliance.